Search
Search Results
##search.searchResults.foundPlural##
-
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
741PDF: 472HTML: 6273 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7661PDF: 2448HTML: 1742Table 1.: 216Table 2.: 226Table 3.: 210Table 4.: 210 -
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus
2730PDF: 1019HTML: 2337 -
WHAT ARE FUNGAL INFECTIONS?
4248PDF: 2417HTML: 27632de Pauw: 244 -
SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY
6147PDF: 3333HTML: 9030Figure Malaria Ricci: 233 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1686PDF: 823HTML: 176 -
POST-LOAD PLASMA GLUCOSE INCREASE (PG-GAP) AS A RISK FACTOR FOR DEVELOPING DYSGLYCEMIA IN PATIENTS WITH TRANSFUSION-DEPENDENT Β-THALASSEMIA (Β-TDT): RETROSPECTIVE ANALYSIS OVER 8 YEARS Post load plasma glucose increase and the risk of glucose dysregulation in thalassemia
519PDF: 253HTML: 43 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4351PDF: 1389HTML: 2051 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1494PDF: 792Suppl. Files: 329Html: 139 -
Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited
1104PDF: 860HTML: 253 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4797PDF: 1571HTML: 2251Untitled: 219Untitled: 235Untitled: 239Untitled: 224Untitled: 227 -
EPIDEMIOLOGY OF IMPORTED MALARIA IN THE MEDITERRANEAN REGION
3155PDF: 1066HTML: 16458 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4564PDF: 1944HTML: 17808 -
A MULTICENTER ICET-A SURVEY ON ADHERENCE TO ANNUAL ORAL GLUCOSE TOLERANCE TEST (OGTT) SCREENING IN TRANSFUSION-DEPENDENT THALASSEMIA (TDT) PATIENTS - THE EXPERT CLINICIANS’ OPINION ON FACTORS INFLUENCING THE ADHERENCE AND ON ALTERNATIVE STRATEGIES FOR ADHERENCE OPTIMIZATION Survey on adherence to annual OGTT in thalassemia
2939PDF: 1354HTML: 161 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3748PDF: 1476HTML: 188 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4326PDF: 3561HTML: 221 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1580PDF: 1044HTML: 238 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3404PDF: 1295HTML: 2230Fi.1 Gritti.Rambaldi: 210 -
-
EARLY PREDICTIVE VALUE OF PERIPHERAL INFLAMMATORY INDEX COMBINED WITH HIGH-SENSITIVITY TROPONIN T FOR SEPSIS-INDUCED CARDIOMYOPATHY Inflammatory and Troponon T in cardiomyopaty from Sepsis
268PDF: 272HTML: 23 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3353PDF: 1369HTML: 2675 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1090PDF: 968HTML: 341 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
2060PDF: 816HTML: 1053 -
-
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5194PDF: 1340HTML: 2756Cover letter: 201 -
NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis
1920PDF: 1065HTML: 301 -
THE PERFORMANCE OF HOMA 2 COMPARED TO DYNAMIC MARKERS OF INSULIN SECRETION AND SENSITIVITY/RESISTANCE FOR PREDICTING DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β-THALASSEMIA: THE EXPERIENCE OF A SINGLE CENTRE HOMA 2 and DYNAMIC MARKERS OF INSULIN SECRETION FOR PREDICTING DYSGLYCEMIA in TDT
99PDF: 78HTML: 14 -
-
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4155PDF: 1976HTML: 1775 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2455PDF: 874HTML: 2463







